Christopher Pinder is a research technician and PhD student working in Prof. Robin Shattock's research group, Mucosal Infection and Immunity. He primarily works on isolating and characterizing monoclonal antibodies to different pathogens that have been elicited through infection or vaccination, including novel vaccine candidates currently being trialed by the GcLP team. He is currently involved with several vaccine trials concerning Chlamydia trachomatis and HIV, and is working on the development of novel assays to investigate humoral responses to them.
Christopher was awarded a BSc (Hons) in Biomedical Sciences from the University of Southampton in 2009. He then worked as a research technician at Kings College London for Prof. Timothy Vyse, working on identifying novel genetic risk factors for SLE through a large scale GWAS and investigating their functional effects by cell-based assays. In 2014 he joined Prof. Robin Shattock's group as a research technician, before registering as a PhD student in 2017.
Pinder CL, McKay PF, Shattock RJ, 2021, Use of chlamydial elementary bodies as probes to isolate pathogen-specific human monoclonal antibodies., Methods in Molecular Biology, Vol:2183, ISSN:1064-3745, Pages:19-28
et al., 2017, Isolation and Characterization of Antigen-Speciﬁc Plasmablasts Using a Novel Flow Cytometry–Based Ig Capture Assay, Journal of Immunology, ISSN:1550-6606
et al., 2017, Dysregulated CD46 shedding interferes with Th1-contraction in systemic lupus erythematosus, European Journal of Immunology, Vol:47, ISSN:0014-2980, Pages:1200-1210
et al., 2015, Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus, Nature Genetics, Vol:47, ISSN:1546-1718, Pages:1457-1464